Skip to content
#protein folding Open access

A BSCB‐Penetrating Nanoplatform for Enhanced Luteolin Delivery in PRMT2‐Targeted Epigenetic Therapy of Spinal Cord Injury

Sep 2026 · Advancement of science · 0 citations · 63 references
Medicine

TL;DR

Findings suggest that MSN‐BO@LUT not only provides a developed, safe, effective nanotherapeutic strategy for SCI treatment but also serves as a translatable template for developing precision nanomedicines targeting CNS disorders.

Abstract

ABSTRACT Spinal cord injury (SCI) is a devastating disorder of the central nervous system (CNS) leading to irreversible neurological deficits. Effective pharmacotherapy remains elusive, due to the restrictive blood‐spinal cord barrier (BSCB), underscoring the urgent need for targeted and efficient drug delivery strategies. Luteolin (LUT), a natural flavonoid with potent anti‐neuroinflammatory properties, presents a promising therapeutic option; however, it is compromised by poor solubility, low bioavailability, and limited BSCB penetration. Drawing inspiration from the traditional Chinese medicine concept of the “orifice‐opening” effect of borneol (BO), we developed BO‐modified mesoporous silica nanoparticles (MSN‐BO@LUT) for targeted LUT delivery to the spinal cord. MSN‐BO@LUT significantly enhanced LUT delivery to the spinal cord, achieving a 286.36‐fold increase over LUT, and maintained a concentration of 802.17 ng/mL at 24 h. MSN‐BO@LUT demonstrated robust anti‐neuroinflammatory and neuroprotective effects in SCI mice, reducing microglial infiltration, promoting functional recovery, and showing favorable efficacy and safety compared with the positive control methylprednisolone. Mechanistically, released LUT targets protein arginine N‐methyltransferase, reduces toll‐like receptor 4 methylation, and inhibits nuclear factor kappa B‐mediated pro‐inflammatory signaling, thereby suppressing microglial M1 polarization. These findings suggest that MSN‐BO@LUT not only provides a developed, safe, effective nanotherapeutic strategy for SCI treatment but also serves as a translatable template for developing precision nanomedicines targeting CNS disorders.

Read PDF

Similar papers

Aug 2026

RVG‐Functionalized Liposomal Mollugin: A Targeted Nanotherapy for Spinal Cord Injury

A RVG‐modified liposomal nanoplatform for targeted delivery of mollugin (Mol@Lip‐RVG) as a novel therapeutic strategy for SCI resulted in enhanced neuro‐preservation and substantial improvement in motor function recovery, achieved through dual modulation of microglial reprogramming and attenuation of oxidative stress.

Quan Zhou, I. Shaikh, Jian-Feng Wang et al. · 0 citations
Sep 2026

An H₂O₂/Acidic Microenvironment-Responsive Theranostic Nanoplatform Promotes Spinal Cord Injury Repair via MRI-Guided Synergistic Anti-Ferroptosis.

The secondary injury cascade following spinal cord injury (SCI) involves complex pathological processes, with the interplay between ferroptosis and oxidative stress serving as a key impediment to neural repair. Ferrostatin-1 (Fer-1), an inhibitor of ferroptosis, faces limitations in clinical translation due to its low...

Meng Wang, Jin-Pei Yang, Qun Zheng et al. · 0 citations
Review Open access Aug 2026

Recent Advances in Exosome‐Based Nanodelivery Systems for Traumatic Brain Injury Treatment

Traumatic brain injury (TBI) is a highly heterogeneous neurological condition with extremely high rates of mortality and disability. Currently, the clinical management of TBI relies primarily on palliative care, whereas complex secondary injury cascades limit the ability of traditional single‐target drugs to achieve...

Jue Zhu, Wei-Quan Liao, Zi-Qin Lian et al. · 0 citations
Review Open access Oct 2026

Biomaterial-Based Controlled Release Systems for Spinal Cord Remyelination.

Spinal cord injury (SCI) triggers a complex secondary injury cascade characterized by oligodendrocyte (OL) death and axonal demyelination, leading to permanent neurological deficits. Despite the presence of endogenous oligodendrocyte progenitor cells (OPCs), the inhibitory microenvironment-marked by inflammation, glial...

E. Petillo, V. Veneruso, E. Frigerio et al. · 0 citations
Open access Sep 2026

An Engineered Biomimetic Nanoreactor With Cascade Functions for Targeted and Combinatorial Therapy of Ischemic Stroke

Ischemic stroke reperfusion injury is driven by oxidative stress and neuroinflammation, but current neuroprotective strategies suffer from poor targeting, limited functionality, and low blood‑‐brain barrier (BBB) penetration. Herein, a multifunctional nanoplatform (RM@HPAN) is constructed: a hollow mesoporous Prussian...

Shao-Fa Li, Ying Wu, Hui-Min Wei et al. · 0 citations

Related blog posts

Google DeepMind Blog Sep 30, 2026

Introducing SynthID Bio

Proof of concept for watermarking AI-generated proteins while preserving biological function.

MIT News · Artificial Intelligence Aug 27, 2026

Looking beyond natural sequences

A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.